Pharmacological Modulation of Peripheral Nerve Excitability
NCT06312254
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
20
Enrollment
OTHER
Sponsor class
Conditions
Peripheral Neuropathy
Interventions
DRUG:
Topical lidocaine 5%
DRUG:
Topical Phenytoin 10%
DRUG:
Topical Mepyramine 2%
OTHER:
Topical Placebo
Sponsor
Aalborg University